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The use of veins as cardiovascular conduits
remains important for cardiovascular surgeons. The
universal response of veins after insertion into the
arterial circulation is the development of intimal
hyperplasia,1 a proliferative smooth muscle cell and
connective tissue lesion, which develops early after
insertion of the vein into the arterial circulation.
Clinically, this process appears to stabilize within the
first 2 postoperative years in most vein grafts. The
development of intimal hyperplasia has been associat-
ed with alterations in the functions of both endothe-
lial and smooth muscle cells.2 Experimental models
and retrieved clinical material have shown alterations
in the contractile and relaxant functions mediated by
the endothelial and smooth muscle cells of vein
grafts.1 Receptor-activated endothelial-derived relax-
ation (mediated with nitric oxide [NO] or
prostanoid) appears to be impaired compared with
the native vein. Smooth muscle cell contractility and
nonendothelial-mediated relaxation are also altered
compared with native vein. These studies suggest
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changes in the endothelial cell and smooth muscle
cell physiologic phenotypes in these vessels as com-
pared with native vessels.1,2 However, most of these
studies on relaxation in vein grafts have focused on
systems that involve cyclic guanosine monophos-
phate–mediated relaxation. The response of vein
grafts to a cyclic adenosine-monophosphate activator
adenosine is, at present, unknown. Adenosine is con-
sidered a major component of local hemostasis in all
organ systems and can regulate a diverse series of
functions, such as bronchoconstriction, smooth mus-
cle cell tone, neurotransmitter release, platelet and
white blood cell function, cardiac rate and contractil-
ity, and renal renin release and lipolysis.3 Endothelial
and smooth muscle cells possess a series of specific
adenosine receptors to produce relaxation under
homeostatic conditions. These adenosine receptors
are, for the most part, coupled to adenylate cyclase;
the high-affinity A1 receptor inhibits the enzyme,
and the low-affinity A2 receptor stimulates the
enzyme. In addition, adenosine-induced relaxation
has been shown in various organ systems to be medi-
ated with NO, prostanoids, and adenosine triphos-
phate–dependent K+ channels. This study examines
in vitro adenosine receptor–mediated responses and
receptor expression in experimental vein grafts, jugu-
lar veins, and carotid arteries of the rabbit.
MATERIALS AND METHODS
Male New Zealand white rabbits weighing 2.0 to
2.5 kg were used in the study. The animals underwent
a right carotid interposition bypass grafting with the
ipsilateral external jugular vein.4 In this model, after 4
weeks, stable intimal hyperplasia developed, with a
confluent endothelium and no evidence of an inflam-
matory infiltrate or residual platelet deposition. The
animals were killed 4 weeks after surgery with pento-
barbital sodium (Anthony Products Co, Arcadia,
Calif). The vein graft, the contralateral jugular vein,
and the common carotid artery were harvested for in
vitro isometric tension studies. Mid portions of the
vein graft were chosen because of the uniform charac-
teristics of the intimal hyperplasia in these areas, which
would minimize changes induced by vein artery mis-
matching, surgical variability, and different degrees of
flow disturbance and intimal hyperplasia develop-
ment. Animal care complied with the “Principles of
Laboratory Animal Care,” as formulated by the
National Society for Medical Research, and the
“Guide for the Care and Use of Laboratory Animals,”
issued by the National Institute of Health (US
Department of Health and Human Services, NIH
Publication No 86-23, revised 1985).
The vein graft, jugular vein, and carotid artery
were isolated as described previously.4 The middle
of each vessel was sectioned in situ into 4 5-mm
segments and excised. Each vessel ring was sus-
pended from 2 stainless steel hooks in 5 mL–capac-
ity organ baths that contained oxygenated Krebs
solution (122 mmol/L NaCl, 4.7 mmol/L KCl,
1.2 mmol/L MgCl2, 2.5 mmol/L CaCl2, 15.4
mmol/L NaHCO3, 1.2 mmol/L KH2PO4 and 5.5
mmol/L glucose). The solution was maintained at
37°C and bubbled with a mixture of 95% O2 and
5% CO2. One hook was fixed to the bottom of the
bath, and the other was connected to a force trans-
ducer (Myograph F-60, Narco Bio-Systems,
Houston, Tex). The isometric responses of the tis-
sue were recorded on a multichannel polygraph
(Physiograph Mk111-S, Narco Bio-Systems). The
tissues then were placed under 0.5g tension and
allowed to equilibrate in physiologic Krebs solution
for 1 hour. During the equilibration period, the
Krebs solution was replaced every 15 minutes. After
equilibration, the optimal resting tension for each
ring was determined by the maximal response to a
modified oxygenated Krebs solution that contained
60 mmol/L KCl, 66.7 mmol/L NaCl, 1.2
mmol/L MgCl2, 2.5 mmol/L CaCl2, 15.4
mmol/L NaHCO3, 1.2 mmol/L KH2PO4, and 5.5
mmol/L glucose at resting tensions ranging from
0.5g to 2.5g. On the basis of these results, each ring
was set at its optimal tension for subsequent dose
response experiments. The potassium chloride [60
mmol/L] contractile responses were 150 ± 50 mg,
300 ± 30 mg, and 820 ± 40 mg for the jugular vein,
vein graft, and carotid artery, respectively. All vessels
(external jugular vein, common carotid artery, and
vein graft) were precontracted with prostaglandin
F2a to achieve 70% of the potassium chloride 
contractile response. Both endothelialized and 
de-endothelialized vessels were examined. De-
endothelialization of the rings was achieved by
mechanical denudation of the rings with a balloon
fogarty (Baxter Healthcare Corp, Irvine, Calif)
embolectomy catheter before mounting and was
confirmed by a lack of relaxation to acetylcholine as
previously described.5
There were 3 series of experiments. In the first
series, the responses to N-ethyl-carboxyamido-
adenosine (NECA; 10-10 to 10-4 mol/L), R-phenyl-
isopropyl-adenosine (R-PIA; 10-10 to 10-4 mol/L;
selective A1 agonist), and CSG-21680 (CSG; 10-10
to 10-4 mol/L; selective A2 agonist) were examined.
In the second series, the effects of xanthine amine 
congener (XAC; 8-4-[2-amino-ethylamino]car-
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bonyl-methyl-oxy-phenyl-1,3-dipropylxanthine;
10-5 mol/L for 30 minutes; specific A1 blockade),
NG-monomethyl-L-arginine (L-NMMA; 10-5 mol/L
for 30 minutes; NO synthesis inhibition), glyben-
clamide (10-5 mol/L for 30 minutes; K+ channel
blockade), and indomethacin (10-5 mol/L for 30
minutes; cyclo-oxygenase inhibition) on the
responses were tested. In the third series, the linkage
of the responses to guanosine triphosphate (GTP)
binding proteins was tested with incubation with
pertussis toxin, an uncoupler of Gi/Go (100 ng/mL
for 60 minutes) that produces complete adenosine
diphosphate ribosylation of Gi/Go in these tissues,
or cholera toxin, an uncoupler of GS (200 ng/mL
for 180 minutes) that promotes complete adenosine
diphospate ribosylation of GS in these tissues.6 All
drugs were obtained from Sigma Chemical Co (St
Louis, Mo).
Membrane preparation and radioligand bind-
ing. Vein grafts, jugular veins, and carotid arteries
were harvested at 28 days and cleaned of all adventi-
tia before radioligand assay studies. The single layer
of endothelial cells is unlikely to make a significant
contribution to the data obtained. For [125I]PAPA-
APEC (2-[4-(2-{[4-aminophenyl]-methylcarbonyl}-
ethyl)-phenyl]-ethylamino-5’-N-ethylcarboxami-
doadenosine) and [125I]APNEA (N5-2-[4-amino-
3-iodophenyl]ethyladenosine) binding, membranes
were prepared as previously described7 and resus-
pended in 50 mmol/L Tris-HCl, 1 mmol/L ethylene-
diamine tetraacetic acid, pH 7.4, that contained 10
mmol/L MgCl2 (50/10) and approximately 3
units/mL adenosine deaminase. Light vesicles were
prepared as previously described.8 Before preparation
of the vesicles, vessels first were treated with con-
canavalin A (0.25 mg/mL) for 30 minutes at 37°C
to prevent sequestration of the A1 adenosine receptor
during the homogenization. [125I]PAPA-APEC and
[125I]APNEA were synthesized and radiolabeled as
described previously.7,9
For A1 adenosine receptor binding, membranes
(20 to 40 m g/assay tube) were incubated for 1 hour
at 37°C with 1 nmol/L [125I]APNEA in a total vol-
ume of 250 m L of 50/10 buffer (50 mmol/L Tris-
HCl, 10 mmol/L MgCl2, 1 mmol/L ethylenedi-
amine tetraacetic acid). This incubation time was
optimal to ensure steady-state binding as determined
from [125I]APNEA association curves (data not
shown). Theophylline (1 mmol/L) was used to
define nonspecific binding, which normally averaged
from 30% to 50% of the total binding. After incuba-
tion, membranes were rapidly filtered over 25 mm
glass fiber filters (No 32; Schleicher and Schuell,
Keene, NH) by vacuum and were washed 3 times
with 3 mL of ice cold 50/10/1 buffer that contained
0.03% CHAPS (3-[(3-cholamidopropyl)dimethy-
lammonio]-1-propansulfonate). Filters were allowed
to extract for at least 12 hours in toluene-based scin-
tillation fluid before counting.
For A2 adenosine receptor binding, membranes
(60 to 100 m g of protein) were incubated for 1 hour
with [125I]PAPA-APEC (1 nmol/L) in a total vol-
ume of 250 m L of 50/10 buffer. Nonspecific bind-
ing was defined with 1 mmol/L theophylline and
averaged about 50% of total binding at a concentra-
tion of the radioligand at the Kd. This concentration
of theophylline was optimal and defined a similar
level of nonspecific binding as that defined by
NECA (100 m mol/L). Separation and counting of
the bound radioligands was performed as described
above. Results are expressed as a ratio of the binding
of A1 to that seen for A2.
Data and statistical analysis. The dose-response
curves were analyzed, and the IC50 value (median
effective inhibitory concentration) for relaxation of
each ring was calculated by logistic analysis and
expressed as the pD2 (–log10[IC50]).10 Where con-
traction occurs, the EC50 value (median effective con-
centration) is reported. Data are presented as the
arithmetric mean ± the standard error of the mean
(SEM). Statistical differences between groups were
tested with either one-way analysis of variance or with
post hoc Tukey-Kramer comparison testing. A P value
of less than .05 was regarded as significant.
RESULTS
Adenosine receptors and their responses.
Radioligand binding studies showed the presence of
A1 and A2 receptors in the vein grafts with a ratio
(A1/A2) of 1.4, in the jugular veins with a ratio of
1.8, and in the carotid arteries with a ratio of 0.5. To
evaluate the effect of adenosine activation on vasore-
laxation, we stimulated all 3 vessels with the adeno-
sine agonist NECA. Vein grafts responded with a
blunted maximal relaxation (up to 10-4 mol/L)
compared with either the jugular vein or the carotid
artery (Figs 1 through 3). Both the jugular veins and
the carotid arteries relaxed in response to NECA
(Figs 2 and 3). The lower doses of the NECA phys-
iologically are more relevant and closer to what is
experienced in the body given the rapid degradation
of adenosine. Thus, the data at the lower concentra-
tions as opposed to the higher concentrations are
more physiologic. Because the effect of adenosine
can be mediated through 2 distinct receptors A1 and
A2, we tested the response of the vessels to the A1
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Fig 1. Adenosine-mediated relaxation in vein grafts. Cumulative dose response curves to
NECA (s), CGS (n) and R-PIA (h) in endothelialized (A) and de-endothelialized (B) vein
grafts. NECA response with (d) and without (s) preincubation with XAC is shown in C.
Values are the mean ± standard error of the mean of percent precontracted tension. Sensitivities
are presented in Tables I and II.
agonist, R-PIA, and the A2 agonist, CGS. R-PIA
induced vasoconstriction in the vein grafts (Fig 1)
and CGS induced endothelium-independent relax-
ation equivalent to NECA. To determine whether
the contractile response to R-PIA was caused by
endothelial cell A1 receptors or A1 smooth muscle
cell receptors, we evaluated the response of endothe-
lial denuded vein graft segments to R-PIA.
Endothelial denudation of the vein graft restored R-
PIA–mediated relaxation (Fig 1) but at a much
reduced level compared with that of jugular vein
(Table I). To evaluate the contribution of A1 recep-
tors to the NECA response, we preincubated the
vein grafts with the A1 antagonist XAC (10-5 mol/L
for 30 minutes). In the presence of XAC, the relax-
ation to NECA in the vein graft was enhanced,
which further suggests that A1 receptors are mediat-
ing contraction instead of relaxation in this vessel.
The contractile response to R-PIA was abolished
and that to CGS was unaffected (Fig 1; Table I).
Similarly, we tested the responses of the jugular
veins and the carotid arteries to the A1 agonist, R-
PIA, and the A2 agonist, CGS. Both R-PIA and CGS
induced endothelium-independent relaxation in the
jugular veins (Table I). After pretreatment with XAC,
the response of the jugular vein to NECA was signif-
icantly reduced (Table I) and the response to R-PIA
was abolished; the response to CGS was unaffected
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Fig 2. Adenosine-mediated relaxation in jugular veins. Cumulative dose response curves to
NECA (s), CGS (n) and R-PIA (h) in endothelialized (A) and de-endothelialized (B) jugu-
lar veins. Values are the mean ± standard error of the mean of percent precontracted tension.
Sensitivities are presented in Tables I and II.
by pretreatment with XAC. In the carotid arteries,
CGS-induced relaxation displayed an endothelial-
based component, but that to R-PIA was endotheli-
um independent (Table II). Preincubation with XAC
did produce a decrease in the response to NECA in
the carotid artery, but this did not achieve signifi-
cance (Table II). In the presence of XAC, the
response to R-PIA was abolished and that to CGS
was unaffected by pretreatment with XAC.
Role of NO, prostaglandins, and membrane
channels. To examine the contribution of NO pro-
duction, prostanoid generation, or K+ channels acti-
vation—each of which are known to contribute to
adenosine-mediated relaxation—the 3 vessels were
preincubated with L-NMMA (a NO synthase
inhibitor), indomethacin (a cyclo-oxygenase
inhibitor), and glybenclamide (K+ channel block-
ade), respectively, before stimulation with NECA.
Relaxation in vein grafts to NECA was sensitive to L-
NMMA and indomethacin inhibition and indepen-
dent of glybenclamide (Table II). The jugular veins
relaxed to NECA with a response that could be par-
tially inhibited by L-NMMA and indomethacin
(Table II). Incubation with glybenclamide had no
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Fig 3. Adenosine-mediated relaxation in carotid arteries. Cumulative dose response curves to
NECA (s), CGS (n) and R-PIA (h) in endothelialized (A) and de-endothelialized 
(B) carotid arteries. Values are the mean ± standard error of the mean of percent precontract-
ed tension. Sensitivities are presented in Tables I and II.
effect on the NECA response (Table II). The carotid
arteries relaxed in response to NECA, and this relax-
ation was sensitive to the presence of indomethacin
and glybenclamide but unaffected by L-NMMA
(Table II). Given the striking differences in the
responses to the respective A1 and A2 agonists, we
performed a similar series of pretreatments before
testing with R-PIA or CGS. In the vein graft, A1-
mediated contractile response was enhanced with
preincubation with L-NMMA (9.05 ± 0.33, P < .05;
mean ± SEM; EC50) and indomethacin (10.5 ±
0.45, P < .05; EC50) but was unaffected with prein-
cubation with glybenclamide as compared with con-
trol (8.21 ± 0.25; EC50). In the vein graft, A2
response was unaffected by denudation (6.42 ±
0.14, mean ± SEM; IC50) and was sensitive to L-
NMMA (5.79 ± 0.14, P < .05; IC50) and
indomethacin (5.86 ± 0.15, P < .05; IC50) but was
independent of glybenclamide (5.64 ± 0.49; IC50)
as compared with control (6.18 ± 0.13; IC50). 
Role of G-proteins. The linkage of the NECA
responses to GTP-binding proteins was tested with
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Table I. Receptor specific responses
R-PIA (A1) Vein graft Jugular vein Carotid artery
Control (10-10 to 10-4 mol/L)* Contraction 6.94 ± 0.24 6.89 ± 0.24
(8.21 ± 0.25)
Denuded (10-10 to 10-4 mol/L)† 5.80 ± 0.24‡ 6.53 ± 0.20 6.64 ± 0.17
CGS-21680 (A2)
Control (10-10 to 10-4 mol/L)§ 6.18 ± 0.13 5.98 ± 0.09 6.16 ± 0.10
Denuded (10-10 to 10-4 mol/L)( 6.42 ± 0.14 6.95 ± 0.09¶ 5.70 ± 0.34#
Values are the pD2 (–log10[IC50]) and are presented as the mean ± standard error of mean. Statistical analysis by analysis of variance with
post hoc Tukey-Kramer comparison testing.
*P = .89 for the comparison of jugular veins and carotid arteries.
†P = .31 for the analysis of variance comparison of denuded jugular veins, vein grafts, and carotid arteries.
‡P < .05 compared with control vein graft.
§P = .47 for the analysis of variance comparison of control jugular veins, vein grafts, and carotid arteries.
(P = .0002 for the analysis of variance comparison of denuded jugular veins, vein grafts, and carotid arteries.
¶P < .001 compared with control jugular vein.
#P < .01 compared with control carotid artery.
Table II. Responses to adenosine
Vein graft Jugular vein Carotid artery
Control (10-10 to 10-4 mol/L)* 7.40 ± 0.23 7.72 ± 0.15 7.64 ± 0.17
Denuded (10-10 to 10-4 mol/L)† 8.61 ± 0.10‡ 6.81 ± 0.15( 5.89 ± 0.53#
Indomethacin (10-5 mol/L) 5.56 ± 0.57§ 6.87 ± 0.25( 5.46 ± 0.44**
NG-monomethyl-L-arginine (10-5 mol/L) 5.79 ± 0.42§ 6.52 ± 0.19¶ 6.62 ± 0.34
Glybenclamide (10-5 mol/L) 6.21 ± 0.15 7.08 ± 0.42 5.97 ± 0.49#
Xanthine amine congener (10-5 mol/L) 8.88 ± 0.06‡ 7.20 ± 0.14( 7.32 ± 0.38
Pertussis toxin (100 ng/mL) 5.31 ± 0.51§ 6.90 ± 0.15( 5.72 ± 0.42**
Cholera toxin (200 ng/mL) No response 7.20 ± 0.38 5.96 ± 0.33#
Values are the pD2 (–log10[IC50]) and are presented as the mean ± standard error of the mean. Statistical analysis by analysis of variance
with post hoc Tukey-Kramer comparison testing.
*P = .45 for the analysis of variance comparison of control jugular veins, vein grafts, and carotid arteries.
†P = .024 for the analysis of variance comparison of denuded jugular veins, vein grafts, and carotid arteries (carotid artery vs vein graft,
P < .05).
‡P < .05 compared with control vein graft.
§P < .01 compared with control vein graft. 
(P < .05 compared with control jugular vein.
¶P < .001 compared with control jugular vein.
#P < .01 compared with control carotid artery.
**P < .001 compared with control carotid artery.
incubation with pertussis toxin (uncoupler of Gi/Go )
or cholera toxin (uncoupler of GS ). Although cholera
toxin abolished the response of the vein grafts to
NECA, a component of this relaxation was also per-
tussis toxin sensitive (Table II). This suggests involve-
ment of both types of alpha subunits (Gi/Go and GS),
with Gs as the predominant GTP-binding protein
linked to the receptor systems. Jugular veins respond-
ed to NECA with pertussis toxin–sensitive but cholera
toxin–insensitive responses, which suggests signal
transduction through Gi/Go alpha subunits (Table
II). Carotid arteries showed pertussis toxin–sensitive
and cholera toxin–sensitive NECA-mediated respons-
es, which suggests signal transduction through both
Gi/Go and GS alpha subunits (Table II). Because of
the different responses to the respective A1 and A2
agonists, we performed a similar series of pretreat-
ments with pertussis and cholera toxins before testing
with R-PIA or CGS. In the vein graft, A1-mediated
contractile response was enhanced by the presence of
pertussis toxin (9.17 ± 0.31; EC50) but was cholera
toxin insensitive as compared with control (8.21 ±
0.25; EC50). In contrast, the A2 responses were
cholera toxin sensitive (no response) and pertussis
toxin insensitive (5.36 ± 0.60; IC50).
DISCUSSION
The physiology of vein grafts after implantation
into the arterial circulation is altered, with changes
noted in the responses of the vein graft’s smooth mus-
cle cells to multiple contractile agonists. Although the
pathologic implications of these responses remain to
be defined, these changes do reflect a change in phys-
iologic phenotype. In concert with these alterations in
the smooth muscle cells, there are changes in the
function of the endothelial cells. The most striking of
these changes has been the reduction in receptor-acti-
vated NO-mediated relaxation and the apparent
changes in the pattern of PGI2 (decreased) and
thromboxane A2 (increased) production. These
changes in important vessel wall modulators are con-
sidered to contribute to the pathologic processes that
lead to the development of intimal hyperplasia in a
vein graft. To date, the actions of adenosine in vein
grafts has not been determined. This study shows that
the responses of the vein grafts to this agonist in rela-
tion to the native vein and artery appear unique. First,
in contrast to the carotid artery, vein graft adenosine-
mediated relaxation is NO and prostanoid dependent,
which is similar to the response of the jugular vein.
Second, A1-receptor activation in the vein graft pro-
duces an endothelium-dependent contractile
response. Third, the A2 receptor–mediated responses
in the vein grafts appear independent of the endothe-
lium. Fourth, radioligand studies confirm the pres-
ence of both receptor subtypes (A1 and A2) on the
vein grafts, with a ratio closer to that of the jugular
vein than to that seen in the carotid artery. And fifth,
adenosine-receptor transduction by G-protein alpha
subunits in the vein graft involves both a i /a o and a S,
which is more like the carotid artery.
Adenosine receptor–activated relaxation could
be inhibited partly with preincubation with a nitric
oxide synthase inhibitor, which suggests for the first
time that receptor-mediated activation of this system
is intact in vein grafts. The results would suggest
that activation of the NOS is A2 receptor mediated.
These findings would further support the results
obtained in this model and in retrieved human vein
grafts that show the presence of constitutive NOS,
which can be activated by nonreceptor-mediated
endothelium-dependent agonists. The conversion of
a receptor-mediated response from relaxation to
contraction has been shown before in these vein
grafts. In the jugular vein, serotonin-mediated
endothelium-dependent relaxation is by activation of
the 5-HT1 receptor. After vein grafting, this response
to serotonin changes from endothelium-dependent
relaxation to endothelium-independent contraction
and appears to be caused by the development of 5-
HT2 receptor subtypes on the smooth muscle cells of
the intimal hyperplasia.11 Similarly, others have
reported that acetylcholine will relax the native vein
and induce contraction in vein grafts, which suggests
a change in the muscarinic receptors from activation
of relaxation to the activation of contraction. The
conclusions from these varied studies are that there is
a defect in receptor activation or signal transduction
in the endothelial cells of the vein graft that reduces
the vessels ability to relax and modulate smooth mus-
cle cells to increase contraction.
Changes in the hemodynamic environment of the
vessel play a role in the functional changes in the
adenosine responses shown for the graft endothelial
cells. This response is composed of 2 components: an
initial response to injury and a prolonged response to
changes in the flow and shear stress across the
endothelial cell monolayer. Altered endothelial cell
signalling, whether by the acetylcholine receptor or
by the adenosine A1 receptor, may reflect the needs
of the endothelium to modulate remodelling of the
vessel wall and allow for adaptive functional respons-
es to accommodate arterial levels of shear stress. The
response to NECA is enhanced when the endotheli-
um is removed. This suggests that activation of A1 on
endothelial cells produces a contractile response that
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is counterbalanced nearly completely by the A2
response on the underlying smooth muscle cells. In
relation to the acetylcholine receptor, it appears that
receptor-induced NO-mediated endothelial-depen-
dent relaxation is disturbed after insertion into the
arterial circulation, with a loss of a response to the
acetylcholine receptor but intact responses to calcium
ionophore (receptor-independent NO-mediated
endothelial-independent relaxation) and sodium
nitroprusside (cGMP-mediated relaxation). We have
shown, in the case of the acetylcholine receptor, that
return of a vein graft to the venous circulation for 14
days after an initial exposure of the vein graft to the
arterial circulation for 14 days will reverse the unre-
sponsiveness of the acetylcholine receptor and allow
receptor-induced NO-mediated endothelium-depen-
dent relaxation. Whether modulation of the adeno-
sine receptor would occur by manipulation of the
hemodynamic environment is not presently known.
Adenosine-mediated relaxation in the jugular
veins and carotid arteries was prostanoid dependent.
Jugular veins also used NO as a secondary mediator,
and carotid arteries used a K+-dependent channel. In
the jugular veins and the carotid arteries, A1-mediat-
ed relaxation (R-PIA) was endothelial independent,
which suggests the presence of A1 receptors on
smooth muscle cells, and A2 responses (CGS) showed
a significant endothelial-dependent component,
which suggests the presence of A2 receptors on both
the endothelial and smooth muscle cells. Relaxation
in the endothelialized carotid arteries was mediated
predominantly by A2 receptors, which is similar to
functional results reported by others for rabbit arteri-
al tissue.12 The radioligand studies in the carotid
arteries confirm the presence of a significant A2-recep-
tor subtype as compared with the A1 subtype. 
A previous study by this laboratory showed that
there was increased expression of a i2 and a S expres-
sion and de novo detectable expression of a i3 in vein
grafts as compared with jugular veins; these changes
were associated with the development of pertussis
toxin–sensitive contractile responses.6 These data sug-
gest that intimal hyperplasia is associated with
increased or novel expression of G-proteins in vivo
coupled with a change in receptor-G protein cou-
pling. Adenosine A1 receptors interact with multiple
G proteins subtypes (a i3 > a i2 > a i1), and adenosine
A2 receptors interact with a S G proteins.13,14 The
ability of pertussis toxin to inhibit a response suggests
the presence of a receptor coupled to a i or a o, and the
ability of cholera toxin to inhibit a response suggests
the presence of a receptor coupled to a S. Most
reports have shown that pertussis toxin–sensitive G
proteins mediate responses for the A1 receptor in a
variety of tissues. The involvement of G proteins in
the response mediated by the A2 response is limited.
In human coronary arteries, A1 and A2 adenosine
responses appear to be mediated by both pertussis
toxin–sensitive and cholera toxin–sensitive recep-
tors.15-17 R-PIA responses in bovine pulmonary
artery endothelial cells have been shown to be pertus-
sis toxin sensitive.18 In this study, we find that adeno-
sine-mediated relaxation in the jugular vein was per-
tussis toxin–sensitive but cholera toxin–insensitive, and
in the carotid artery, the responses were both pertussis
toxin–sensitive and cholera toxin–sensitive, which sug-
gests that a i /a o but not a S participate in the adeno-
sine responses in the jugular vein, but in the carotid
artery, both a i /a o and a S participate in the responses.
The responses in the vein graft appear to be both per-
tussis toxin–dependent and cholera toxin–dependent,
which suggests the participation of both a i /a o and a S
in the responses. Thus, there is a dichotomy existing in
this study. Adenosine-mediated relaxation in the vein
graft is NO-based and prostanoid-based like the jugu-
lar vein, but adenosine-receptor transduction in the
vein graft involves both a i /a o and a S, which is more
like that seen in the carotid artery.
In summary, this study shows that there are
changes in the adenosine-mediated vasoreactivity in
vein grafts as compared with jugular veins because of
a change in endothelial A1 receptor-mediated
response from relaxation to contraction. The adeno-
sine responses of the vein grafts are also different
from the carotid artery. The endothelial cells of the
vein graft appear to have undergone a phenotypic
change, which perhaps involved changes in signal
transduction protein expression and linkages. If one
considers that the changes in adenosine-receptor
responses observed in this study are identifying an
endothelial cell phenotype that is involved in the
intimal hyperplastic process, then all variables that
play a role in initiating intimal hyperplasia in the vein
graft must be considered as possible initiators of the
process. This study has characterized the differences
in the adenosine responses between the 3 vessels, has
shown that there are changes in adenosine respons-
es, and has defined the receptor subtype involved,
the type of G-proteins used, and the possible sec-
ondary mediators responsible. However, we have
not as yet defined the cause of the change in
endothelial cell phenotype, the subtype of A2 recep-
tors present, and the way in which the intracellular
signalling pathways of the A1 and A2 receptors in the
vein grafts are altered. Further studies will be
required to define these pathways. 
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In conclusion, adenosine-mediated responses in
vein grafts appear to be unique on both a functional
and a signal transduction basis. The responses nei-
ther maintain a venous phenotype nor acquire an
arterial phenotype in response to implantation.
We acknowledge the technical assistance of L. Barber.
Microsutures were a gift of Ethicon Inc, Somerville, NJ.
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